She would have periods in time where she’d suddenly wake up in the middle of the day and she couldn’t remember anything from ...

Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

A new national survey shows that, despite intense marketing, most Americans do not want the new weight-loss injectables, such ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

Men, baby boomers, and postgraduate-degree holders were among those most likely to say they wouldn’t choose medication over ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Explore how pharmaceutical researchers are fueling weight loss drug development using biospecimens to unlock the underlying ...